Bigger India
Indian Pharma Lobby Seeks Removal Of India From US Patent Violator List
IPA has drawn the attention of USTR to the rapid progress made by India on a number of fronts, which were cited by USTR while placing India on the Priority Watch List in 2018.
The Indian Pharmaceutical Alliance (IPA), the lobby group for the domestic pharma industry, has filed a submission to the US Trade Representative (USTR) to remove India from its Priority Watch List (PWL), which includes countries that are alleged to have weak enforcement of patent laws.